Consequently, it appears that under the yet-to-be-issued new CTA rules, companies formed in the United States will not have to report their beneficial ownership to FinCEN.

The Corporate Transparency Act is unconstitutional and unenforcable because it infringes on the power to regulate entities that the US Constitution reserved to the states, detractors of the law said ...

The beneficial ownership information (BOI) reporting obligations under the Corporate Transparency Act (CTA ... which (in its current form) would extend the initial report deadline for pre-2024 ...

The U.S. House unanimously passed a bill, now with the Senate, to delay the owner-reporting requirements of the Corporate ...

While the United Kingdom (71) has made recent moves to crack down on dirty money, its efforts risk being undermined by weak progress towards corporate transparency among its overseas territories, ...

Record Year with Total 2024 Revenuesof $161.0Million, Representing a 13% Increase over Fiscal Year 2023 and Adjusted EBITDA of $34.1 Million, Up ...

FinCEN, which enforces BOI requirements under the Corporate Transparency Act (CTA), P.L. 116-283 ... applicants" — defined as any individual who files an application to form a corporation, limited ...

A new study reveals that generic drugs made in India are linked to a significantly higher number of severe adverse events, ...

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 – Statements in this press release regarding ICE's business that ... ICE's Annual Report on Form 10-K for the ...

Explore our review of Navy Federal Credit Union's 2025 mortgage offerings. Learn about rates, loan options, customer service, ...

The study is significant because it is the first to be able to link a large sample of generic drugs to the actual plant where they were manufactured. The FDA will not release that information through ...